Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.

被引：1
|
作者：
An, Josiah
Yan, Melissa
Yu, Nanmeng
Chennamadhavuni, Adithya
Furqan, Muhammad
Kruser, Timothy
Sita, Timothy L.
Nguyen, Ryan
Feldman, Lawrence Eric
Pasquinelli, Mary
Hanna, Nasser H.
Abu Hejleh, Taher
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Iowa, Iowa City, IA USA
[4] Northwestern Mem Hosp, Chicago, IL 60611 USA
[5] Western Univ, Coll Osteopath Med Pacific, Pomona, CA USA
[6] Univ Illinois, Canc Ctr, Chicago, IL USA
[7] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9033
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Retinoblastoma mutation to predict poor outcomes in non-small cell lung cancer (NSCLC).
    Bhateja, Priyanka
    Wildey, Gary
    Fu, Pingfu
    Lipka, Mary Beth
    Ardeshir-Larijani, Fatemeh
    Sharma, Neelesh
    Dowlati, Afshin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer
    Principe, Daniel R.
    Pasquinelli, Mary M.
    Nguyen, Ryan H.
    Munshi, Hidayatullah G.
    Hulbert, Alicia
    Aissa, Alexandre F.
    Weinberg, Frank
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 2282 - 2294
  • [33] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [34] Immunogenomic analysis identifies the complement pathway as a therapeutic target in STK11 mutant non-small cell lung cancer
    Yau, Edwin H.
    Kandar, Bojidar
    Deng, Lei
    Chen, Te-An
    Bshara, Wiam
    Glenn, Sean
    Pabla, Sarabjot
    Papanicolau-Sengos, Antonios
    Nesline, Mary
    Chen, Hongbin
    Early, Amy
    Morrison, Carl
    Dy, Grace
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [35] Outcomes of Concurrent Chemoradiotherapy in Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Lee, Seok Ho
    Lee, Seung Heon
    Heo, Ho-Jin
    Sung, Kihoon
    Lee, Kyu Chan
    Jung, Sung Hwan
    Park, Jeong Woong
    Cho, Eun Kyung
    Ahn, Hee Kyung
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S685
  • [36] Loss of STK11 suppresses lipid metabolism to attenuate KRAS-induced immunogenicity in patients with non-small cell lung cancer
    Principe, Daniel
    Pasquinelli, Mary
    Nguyen, Ryan
    Feldman, Lawrence
    Aissa, Alexandre
    Weinberg, Frank D.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [37] Stage III Non-small Cell Lung Cancer
    Rusch, Valerie W.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 727 - 735
  • [38] Impact of STK11 copy loss on clinical outcomes to PD-(L)1 blockade in non-small cell lung cancer.
    Gutierrez, Catherine
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Pecci, Federica
    De Castro Barrichello, Adriana Paula
    Vaz, Victor R.
    Sholl, Lynette M.
    Awad, Mark M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Molecular Spectrum of STK11 Gene Mutations in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
    Chen, X.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2099 - S2100
  • [40] Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses
    Xu, Ke
    Lu, Weinan
    Yu, Airu
    Wu, Hongwei
    He, Jie
    [J]. BMC CANCER, 2024, 24 (01)
12345